Susquehanna International Group’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-68,457
| Closed | -$1.62M | – | 6898 |
|
|
2023
Q4 | $1.62M | Sell |
68,457
-87,596
| -56% | -$2.07M | ﹤0.01% | 2180 |
|
|
2023
Q3 | $2.33M | Buy |
156,053
+37,087
| +31% | +$553K | ﹤0.01% | 1706 |
|
|
2023
Q2 | $1.3M | Sell |
118,966
-1,065,457
| -90% | -$11.7M | ﹤0.01% | 2397 |
|
|
2023
Q1 | $10.3M | Buy |
1,184,423
+782,755
| +195% | +$6.83M | ﹤0.01% | 722 |
|
|
2022
Q4 | $2.52M | Buy |
401,668
+290,384
| +261% | +$1.82M | ﹤0.01% | 1409 |
|
|
2022
Q3 | $389K | Buy |
+111,284
| New | +$389K | ﹤0.01% | 3889 |
|
|
2022
Q2 | – | Sell |
-36,418
| Closed | -$113K | – | 6895 |
|
|
2022
Q1 | $113K | Buy |
36,418
+25,573
| +236% | +$79.3K | ﹤0.01% | 5098 |
|
|
2021
Q4 | $37K | Buy |
+10,845
| New | +$37K | ﹤0.01% | 5541 |
|
|
2021
Q3 | – | Sell |
-76,433
| Closed | -$333K | – | 6269 |
|
|
2021
Q2 | $333K | Sell |
76,433
-35,196
| -32% | -$153K | ﹤0.01% | 4349 |
|
|
2021
Q1 | $507K | Buy |
111,629
+33,506
| +43% | +$152K | ﹤0.01% | 3831 |
|
|
2020
Q4 | $448K | Buy |
+78,123
| New | +$448K | ﹤0.01% | 3520 |
|
|
2020
Q3 | – | Sell |
-275,877
| Closed | -$963K | – | 5119 |
|
|
2020
Q2 | $963K | Buy |
275,877
+187,162
| +211% | +$653K | ﹤0.01% | 2204 |
|
|
2020
Q1 | $131K | Buy |
88,715
+2,820
| +3% | +$4.16K | ﹤0.01% | 3963 |
|
|
2019
Q4 | $168K | Buy |
85,895
+9,218
| +12% | +$18K | ﹤0.01% | 3559 |
|
|
2019
Q3 | $393K | Buy |
76,677
+48,035
| +168% | +$246K | ﹤0.01% | 3141 |
|
|
2019
Q2 | $205K | Buy |
+28,642
| New | +$205K | ﹤0.01% | 3877 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4807 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5102 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4946 |
|
|
2018
Q2 | – | Sell |
-84,267
| Closed | -$1.1M | – | 4937 |
|
|
2018
Q1 | $1.1M | Buy |
84,267
+31,367
| +59% | +$408K | ﹤0.01% | 1410 |
|
|
2017
Q4 | $487K | Buy |
52,900
+24,610
| +87% | +$227K | ﹤0.01% | 2427 |
|
|
2017
Q3 | $228K | Buy |
28,290
+14,941
| +112% | +$120K | ﹤0.01% | 2664 |
|
|
2017
Q2 | $77K | Buy |
+13,349
| New | +$77K | ﹤0.01% | 3298 |
|
|
2016
Q1 | – | Sell |
-25,405
| Closed | -$43K | – | 4519 |
|
|
2015
Q4 | $43K | Buy |
+25,405
| New | +$43K | ﹤0.01% | 4065 |
|
|
2015
Q2 | – | Sell |
-54,108
| Closed | -$374K | – | 4808 |
|
|
2015
Q1 | $374K | Buy |
+54,108
| New | +$374K | ﹤0.01% | 3314 |
|